Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients

被引:17
|
作者
Veschetti, Laura [1 ]
Sandri, Angela [2 ]
Patuzzo, Cristina [1 ]
Melotti, Paola [3 ]
Malerba, Giovanni [1 ]
Lleo, Maria M. [2 ]
机构
[1] Univ Verona, Dept Neurosci Biomed & Movement Sci, I-37134 Verona, Italy
[2] Univ Verona, Dept Diagnost & Publ Hlth, Microbiol Sect, I-37134 Verona, Italy
[3] Azienda Osped Univ Integrata Verona, Cyst Fibrosis Ctr, I-37126 Verona, Italy
来源
MICROBIAL GENOMICS | 2021年 / 7卷 / 07期
关键词
Achromobacter; cystic fibrosis; lung infection; bacterial evolution; comparative genomics; virulence factors; antibiotic resistance; hypermutation; HYPERMUTABLE PSEUDOMONAS-AERUGINOSA; METALLO-BETA-LACTAMASE; MOLECULAR CHARACTERIZATION; GENETIC ADAPTATION; XYLOSOXIDANS; PREVALENCE; RESISTANCE; DATABASE; STRAINS;
D O I
10.1099/mgen.0.000606
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Achromobacter species are increasingly being detected in cystic fibrosis (CF) patients, where they can establish chronic infections by adapting to the lower airway environment. To better understand the mechanisms contributing to a successful colonization by Achromobacter species, we sequenced the whole genome of 54 isolates from 26 patients with occasional and early/late chronic lung infection. We performed a phylogenetic analysis and compared virulence and resistance genes, genetic variants and mutations, and hypermutability mechanisms between chronic and occasional isolates. We identified five Achromobacter species as well as two non- affiliated genogroups (NGs). Among them were the frequently isolated Achromobacter xylosoxidans and four other species whose clinical importance is not yet clear: Achromobacter insuavis, Achromobacter dolens, Achromobacter insolitus and Achromobacter aegrifaciens. While A. insuavis and A. dolens were isolated only from chronically infected patients and A. aegrifaciens only from occasionally infected patients, the other species were found in both groups. Most of the occasional isolates lacked functional genes involved in invasiveness, chemotaxis, type 3 secretion system and anaerobic growth, whereas the great majority ( 1 year from first colonization) and 78% of late chronic ( 1 year from first colonization) isolates were classified as hypermutators. Although all A. dolens, A. insuavis and NG isolates presented two different mutS genes, these seem to have a complementary rather than compensatory function. In conclusion, our results show that Achromobacter species can exhibit different adaptive mechanisms and some of these mechanisms might be more useful than others in establishing a chronic infection in CF patients, highlighting their importance for the clinical setting and the need for further studies on the less clinically characterized Achromobacter species.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Genomic analysis of Staphylococcus aureus sequential isolates from lungs of patients with cystic fibrosis
    Ding, Xiongqi
    Fu, Xiali
    Euphrasie, Daniel
    Ferroni, Agnes
    Sermet-Gaudelus, Isabelle
    Charbit, Alain
    Coureuil, Mathieu
    Jamet, Anne
    MICROBES AND INFECTION, 2023, 25 (06)
  • [32] Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report
    Hoyle, N.
    Zhvaniya, P.
    Balarjishvili, N.
    Bolkvadze, D.
    Nadareishvili, L.
    Nizharadze, D.
    Wittmann, J.
    Rohde, C.
    Kutateladze, M.
    RESEARCH IN MICROBIOLOGY, 2018, 169 (09) : 540 - 542
  • [33] Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study
    Esposito, Alfonso
    Pompilio, Arianna
    Bettua, Clotilde
    Crocetta, Valentina
    Giacobazzi, Elisabetta
    Fiscarelli, Ersilia
    Jousson, Olivier
    Di Bonaventura, Giovanni
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [34] Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
    Firmida, M. C.
    Pereira, R. H. V.
    Silva, E. A. S. R.
    Marques, E. A.
    Lopes, A. J.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2016, 49 (04)
  • [35] Prevalence and species distribution of Achromobacter sp cultured from cystic fibrosis patients attending the Aarhus centre in Denmark
    Gade, Sinne Soberg
    Norskov-Lauritsen, Niels
    Ridderberg, Winnie
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (05) : 686 - 689
  • [36] Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates
    Tramper-Stranders, G. A.
    van der Ent, C. K.
    Molin, S.
    Yang, L.
    Hansen, S. K.
    Rau, M. H.
    Ciofu, O.
    Johansen, H. K.
    Wolfs, T. F. W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (06) : 567 - 574
  • [37] Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
    Marsac, Charlotte
    Berdah, Laura
    Thouvenin, Guillaume
    Sermet-Gaudelus, Isabelle
    Corvol, Harriet
    ERJ OPEN RESEARCH, 2021, 7 (02)
  • [38] Characterization of Staphylococcus aureus isolates from pediatric patients with cystic fibrosis
    Liu, Ying
    Zhang, Jiang
    Zhong, Dengke
    Ji, Lu
    Yang, Junshu
    Phillips, James
    Ji, Yinduo
    WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2016, 32 (10)
  • [39] Genomic Variation among Contemporary Pseudomonas aeruginosa Isolates from Chronically Infected Cystic Fibrosis Patients
    Chung, Jade C. S.
    Becq, Jennifer
    Fraser, Louise
    Schulz-Trieglaff, Ole
    Bond, Nicholas J.
    Foweraker, Juliet
    Bruce, Kenneth D.
    Smith, Geoffrey P.
    Welch, Martin
    JOURNAL OF BACTERIOLOGY, 2012, 194 (18) : 4857 - 4866
  • [40] Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: First French data
    Amoureux, Lucie
    Bador, Julien
    Siebor, Eliane
    Taillefumier, Nathalie
    Fanton, Annlyse
    Neuwirth, Catherine
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (02) : 170 - 176